Stocktoria
GN Store Nord A/S GN.CO
DK · Nasdaq Copenhagen · XCSE · stock · Healthcare · website
GN Store Nord A/S financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | kr 16.8B | kr 18.0B | kr 18.1B | kr 18.7B |
| Gross profit | kr 9.2B | kr 9.6B | kr 8.9B | kr 9.1B |
| R&D expense | kr 1.5B | kr 1.5B | kr 1.5B | kr 1.4B |
| SG&A expense | kr 2.3B | kr 2.4B | kr 2.2B | kr 6.2B |
| Operating income | kr 1.6B | kr 1.8B | kr 943.0M | kr 1.1B |
| Interest expense | kr 396.0M | kr 379.0M | kr 326.0M | kr 186.0M |
| Income tax | kr 204.0M | kr 302.0M | kr 77.0M | kr 155.0M |
| Net income | kr 653.0M | kr 988.0M | kr 228.0M | kr 511.0M |
| EPS (diluted) | kr 4.48 | kr 6.78 | kr 1.64 | kr 3.99 |
| Operating cash flow | kr 2.7B | kr 2.7B | kr 2.6B | kr 627.0M |
| Free cash flow | kr 1.1B | kr 1.3B | kr 1.2B | -kr 1.0B |
| Cash & equivalents | kr 1.1B | kr 980.0M | kr 2.2B | kr 990.0M |
| Inventory | kr 2.3B | kr 2.6B | kr 2.7B | kr 3.5B |
| Total assets | kr 29.2B | kr 30.6B | kr 30.6B | kr 30.6B |
| Total liabilities | kr 18.3B | kr 19.8B | kr 21.1B | kr 23.8B |
| Shareholders' equity | kr 10.9B | kr 10.8B | kr 9.6B | kr 6.8B |
Growth · year-over-year · Revenue CAGR -3.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -6.7% | -0.7% | -3.0% | — |
| Net income growth | -33.9% | +333.3% | -55.4% | — |
| EPS growth | -33.9% | +313.4% | -58.9% | — |
| Free cash flow growth | -13.9% | +9.5% | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · DK · as of 2025-12-31. Figures in DKK; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.